Testing for mismatch repair (MMR) and microsatellite instability (MSI) among patients with colorectal cancer (CRC) increased from 22.7% in 2012 to 71.5% in 2021, but variations in access remain, with ...

NORTHFIELD, Ill.--(BUSINESS WIRE)--Recognizing a need for evidence-based recommendations to guide molecular testing in the management of patients with cancer, the College of American Pathologists (CAP ...

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies, and can guide treatment decisions for patients with Lynch-associated cancers LEIDEN, Netherlands & ...

A novel xenonucleic acid mediated molecular clamping technology for early colorectal cancer diagnostics. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not ...

Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancer Largest real-world, blinded, multi-site validation of AI molecular profiling from ...

MSI by NGS allowed for simultaneous screening for LS and categorization of EC into molecular subtypes with prognostic and therapeutic implications. NGS readily identified the four EC molecular ...

Please provide your email address to receive an email when new articles are posted on . Although testing for microsatellite instability and mismatch repair deficiency has increased for advanced ...

Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it ...

In today’s era of precision medicine, the management of most solid tumors is increasingly driven by biomarker testing, the results of which often drive treatment decisions. Perhaps the first ...

Cambridge, UK, 29th January — Panakeia, the world's first in silico multi-omics company, today announced the publication of a landmark clinical validation study in npj Digital Medicine demonstrating ...

Largest real-world, blinded, multi-site validation of AI molecular profiling from routine diagnostic images Software identifies clinically actionable cancer biomarkers in minutes rather than weeks ...